Literature DB >> 16340230

Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey.

Ibrahim Halil Bahcecioglu1, Mehmet Koruk, Omer Yilmaz, Cengiz Bolukbas, Fusun Bolukbas, Ilyas Tuncer, Huseyin Ataseven, Kendal Yalcin, Ibrahim H Ozercan.   

Abstract

OBJECTIVE: To identify the demographic and clinicopathological characteristics of patients diagnosed with nonalcoholic fatty liver disease (NAFLD) and the risk factors for fibrosis based on histopathological findings in East-Southeastern Anatolia regions in Turkey. SUBJECTS AND METHODS: The study included a total of 93 patients diagnosed with NAFLD from 5 different centers. Histopathological findings were evaluated by dividing them into four categories using Matteoni classifications. Cases with fibrosis were further evaluated using Brunt classifications.
RESULTS: The patients with a nonalcoholic fatty liver were in the 3rd and 4th decade age groups. The mean age was 38 years, 76% of the patients were male, 85% were overweight, 37% were obese, 18% had type 2 diabetes mellitus, and 80.6% had hyperlipidemia. A multiple regression analysis showed that age, type 2 diabetes mellitus, and aspartate aminotransferase (AST) levels were linked with the severity of the disease. Of the 93 patients, 55 (59.1%) had fibrosis, of which 10.8% were classified as severe. The severity of fibrosis was significantly higher in obese patients.
CONCLUSIONS: The risk factors for severity of NAFLD included advanced age, type 2 diabetes mellitus and serum AST level, while the risk factor for the severity of fibrosis was obesity.

Entities:  

Mesh:

Year:  2006        PMID: 16340230     DOI: 10.1159/000089388

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  5 in total

1.  Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease.

Authors:  Mehmet Derya Demirag; Hacer Ilke Onen; Meral Yirmibes Karaoguz; Ibrahim Dogan; Tarkan Karakan; Abdullah Ekmekci; Galip Guz
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 2.  Non-alcoholic fatty liver disease: A growing public health problem in Turkey.

Authors:  Eda Kaya; Yusuf Yılmaz
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

Review 3.  Managing nonalcoholic fatty liver disease: recommendations for family physicians.

Authors:  Ignazio Grattagliano; Piero Portincasa; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

4.  Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).

Authors:  Rohit Kohli; Shikha Sunduram; Marialena Mouzaki; Sabina Ali; Pushpa Sathya; Stephanie Abrams; Stavra A Xanthakos; Miriam Vos; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2016-01-01       Impact factor: 4.406

5.  The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania.

Authors:  Jonas Valantinas; Daiva Asta Apanaviciene; Ligita Maroziene; Audrius Sveikata
Journal:  Med Sci Monit       Date:  2012-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.